Logo image of PCE1.DE

BOOKING HOLDINGS INC (PCE1.DE) Stock Fundamental Analysis

FRA:PCE1 - Deutsche Boerse Ag - US09857L1089 - Common Stock - Currency: EUR

4696  +2 (+0.04%)

Fundamental Rating

6

Taking everything into account, PCE1 scores 6 out of 10 in our fundamental rating. PCE1 was compared to 56 industry peers in the Hotels, Restaurants & Leisure industry. Both the health and profitability get an excellent rating, making PCE1 a very profitable company, without any liquidiy or solvency issues. PCE1 is quite expensive at the moment. It does show a decent growth rate. With these ratings, PCE1 could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year PCE1 was profitable.
PCE1 had a positive operating cash flow in the past year.
PCE1 had positive earnings in each of the past 5 years.
Each year in the past 5 years PCE1 had a positive operating cash flow.
PCE1.DE Yearly Net Income VS EBIT VS OCF VS FCFPCE1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

PCE1 has a Return On Assets of 20.00%. This is amongst the best in the industry. PCE1 outperforms 98.21% of its industry peers.
PCE1 has a Return On Invested Capital of 58.08%. This is amongst the best in the industry. PCE1 outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PCE1 is significantly above the industry average of 11.11%.
The 3 year average ROIC (39.14%) for PCE1 is below the current ROIC(58.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20%
ROE N/A
ROIC 58.08%
ROA(3y)16.97%
ROA(5y)11.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.14%
ROIC(5y)26.17%
PCE1.DE Yearly ROA, ROE, ROICPCE1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

The Profit Margin of PCE1 (22.58%) is better than 92.86% of its industry peers.
PCE1's Profit Margin has declined in the last couple of years.
PCE1's Operating Margin of 32.77% is amongst the best of the industry. PCE1 outperforms 96.43% of its industry peers.
In the last couple of years the Operating Margin of PCE1 has remained more or less at the same level.
Industry RankSector Rank
OM 32.77%
PM (TTM) 22.58%
GM N/A
OM growth 3Y13.4%
OM growth 5Y-1.21%
PM growth 3Y32.58%
PM growth 5Y-5.16%
GM growth 3YN/A
GM growth 5YN/A
PCE1.DE Yearly Profit, Operating, Gross MarginsPCE1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PCE1 is creating value.
PCE1 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PCE1 has been reduced compared to 5 years ago.
PCE1 has a worse debt/assets ratio than last year.
PCE1.DE Yearly Shares OutstandingPCE1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
PCE1.DE Yearly Total Debt VS Total AssetsPCE1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

PCE1 has an Altman-Z score of 6.99. This indicates that PCE1 is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of PCE1 (6.99) is better than 94.64% of its industry peers.
PCE1 has a debt to FCF ratio of 1.89. This is a very positive value and a sign of high solvency as it would only need 1.89 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.89, PCE1 belongs to the top of the industry, outperforming 80.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.89
Altman-Z 6.99
ROIC/WACC6.45
WACC9.01%
PCE1.DE Yearly LT Debt VS Equity VS FCFPCE1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

PCE1 has a Current Ratio of 1.22. This is a normal value and indicates that PCE1 is financially healthy and should not expect problems in meeting its short term obligations.
PCE1 has a better Current ratio (1.22) than 73.21% of its industry peers.
PCE1 has a Quick Ratio of 1.22. This is a normal value and indicates that PCE1 is financially healthy and should not expect problems in meeting its short term obligations.
PCE1 has a better Quick ratio (1.22) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
PCE1.DE Yearly Current Assets VS Current LiabilitesPCE1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

More info and screens

6

3. Growth

3.1 Past

PCE1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.37%, which is quite good.
PCE1 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.66% yearly.
The Revenue has grown by 9.47% in the past year. This is quite good.
PCE1 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.52% yearly.
EPS 1Y (TTM)18.37%
EPS 3Y60.13%
EPS 5Y12.66%
EPS Q2Q%21.68%
Revenue 1Y (TTM)9.47%
Revenue growth 3Y29.39%
Revenue growth 5Y9.52%
Sales Q2Q%7.86%

3.2 Future

Based on estimates for the next years, PCE1 will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.37% on average per year.
PCE1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.93% yearly.
EPS Next Y16.7%
EPS Next 2Y15.73%
EPS Next 3Y15.99%
EPS Next 5Y15.37%
Revenue Next Year10.04%
Revenue Next 2Y9.05%
Revenue Next 3Y8.95%
Revenue Next 5Y7.93%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PCE1.DE Yearly Revenue VS EstimatesPCE1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
PCE1.DE Yearly EPS VS EstimatesPCE1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100 200 300 400 500

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.64 indicates a quite expensive valuation of PCE1.
PCE1's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.82, PCE1 is valued at the same level.
PCE1 is valuated rather expensively with a Price/Forward Earnings ratio of 21.12.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PCE1 indicates a somewhat cheap valuation: PCE1 is cheaper than 64.29% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. PCE1 is around the same levels.
Industry RankSector Rank
PE 27.64
Fwd PE 21.12
PCE1.DE Price Earnings VS Forward Price EarningsPCE1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PCE1 is valued a bit more expensive than 64.29% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PCE1 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 20.37
EV/EBITDA 20.37
PCE1.DE Per share dataPCE1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 -200 400 600

4.3 Compensation for Growth

PCE1's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PCE1 has a very decent profitability rating, which may justify a higher PE ratio.
PCE1's earnings are expected to grow with 15.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.65
PEG (5Y)2.18
EPS Next 2Y15.73%
EPS Next 3Y15.99%

More info and screens

3

5. Dividend

5.1 Amount

PCE1 has a yearly dividend return of 0.70%, which is pretty low.
Compared to an average industry Dividend Yield of 2.94, PCE1 pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.70, PCE1 pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.7%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PCE1.DE Yearly Dividends per sharePCE1.DE Yearly Dividends per shareYearly Dividends per share 2024 2025 10 20 30

5.3 Sustainability

PCE1 pays out 21.95% of its income as dividend. This is a sustainable payout ratio.
DP21.95%
EPS Next 2Y15.73%
EPS Next 3Y15.99%
PCE1.DE Yearly Income VS Free CF VS DividendPCE1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
PCE1.DE Dividend Payout.PCE1.DE Dividend Payout, showing the Payout Ratio.PCE1.DE Dividend Payout.PayoutRetained Earnings

More info and screens

BOOKING HOLDINGS INC

FRA:PCE1 (5/23/2025, 7:00:00 PM)

4696

+2 (+0.04%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners94.14%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap152.81B
Analysts78.26
Price Target4920.37 (4.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.7%
Yearly Dividend31.15
Dividend Growth(5Y)N/A
DP21.95%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.71%
Min EPS beat(2)13.06%
Max EPS beat(2)40.35%
EPS beat(4)4
Avg EPS beat(4)16.64%
Min EPS beat(4)6.1%
Max EPS beat(4)40.35%
EPS beat(8)8
Avg EPS beat(8)18.25%
EPS beat(12)12
Avg EPS beat(12)14.45%
EPS beat(16)15
Avg EPS beat(16)31.46%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)1.73%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)1.89%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)7
Avg Revenue beat(12)0.79%
Revenue beat(16)11
Avg Revenue beat(16)2.14%
PT rev (1m)-5.48%
PT rev (3m)-6.9%
EPS NQ rev (1m)0.9%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)2.54%
EPS NY rev (3m)3.2%
Revenue NQ rev (1m)2.66%
Revenue NQ rev (3m)2.27%
Revenue NY rev (1m)2.19%
Revenue NY rev (3m)2.08%
Valuation
Industry RankSector Rank
PE 27.64
Fwd PE 21.12
P/S 7.17
P/FCF 20.37
P/OCF 19.41
P/B N/A
P/tB N/A
EV/EBITDA 20.37
EPS(TTM)169.91
EY3.62%
EPS(NY)222.35
Fwd EY4.73%
FCF(TTM)230.49
FCFY4.91%
OCF(TTM)241.91
OCFY5.15%
SpS654.52
BVpS-166.09
TBVpS-278.83
PEG (NY)1.65
PEG (5Y)2.18
Profitability
Industry RankSector Rank
ROA 20%
ROE N/A
ROCE 73.09%
ROIC 58.08%
ROICexc N/A
ROICexgc N/A
OM 32.77%
PM (TTM) 22.58%
GM N/A
FCFM 35.22%
ROA(3y)16.97%
ROA(5y)11.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.14%
ROIC(5y)26.17%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)49.26%
ROCE(5y)32.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y13.4%
OM growth 5Y-1.21%
PM growth 3Y32.58%
PM growth 5Y-5.16%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.89
Debt/EBITDA 1.81
Cap/Depr 69.08%
Cap/Sales 1.74%
Interest Coverage 7.23
Cash Conversion 104.73%
Profit Quality 155.95%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 6.99
F-Score8
WACC9.01%
ROIC/WACC6.45
Cap/Depr(3y)74.21%
Cap/Depr(5y)71.46%
Cap/Sales(3y)1.86%
Cap/Sales(5y)2.51%
Profit Quality(3y)166.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.37%
EPS 3Y60.13%
EPS 5Y12.66%
EPS Q2Q%21.68%
EPS Next Y16.7%
EPS Next 2Y15.73%
EPS Next 3Y15.99%
EPS Next 5Y15.37%
Revenue 1Y (TTM)9.47%
Revenue growth 3Y29.39%
Revenue growth 5Y9.52%
Sales Q2Q%7.86%
Revenue Next Year10.04%
Revenue Next 2Y9.05%
Revenue Next 3Y8.95%
Revenue Next 5Y7.93%
EBIT growth 1Y27.7%
EBIT growth 3Y46.73%
EBIT growth 5Y8.2%
EBIT Next Year21.52%
EBIT Next 3Y15.45%
EBIT Next 5Y13.18%
FCF growth 1Y14.61%
FCF growth 3Y46.4%
FCF growth 5Y11.91%
OCF growth 1Y14.89%
OCF growth 3Y43.44%
OCF growth 5Y11.34%